Avantor, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount
Avantor, Inc. (AVTR) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount of -$22.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingenciesOther · last filed 2025-02-07
- Avantor, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2024 was -$22.70M, a 2622.22% decline from fiscal 2023.
- Avantor, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2023 was $900.00K.
- Avantor, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2022 was -$1.10M, a 110.28% decline from fiscal 2021.
- Avantor, Inc. effective income tax rate reconciliation, tax contingency, other, amount for fiscal 2021 was $10.70M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount 12 month |
|---|---|
| 2024-12-31 | -$22.70M 10-K · filed 2025-02-07 |
| 2023-12-31 | $900.00K 10-K · filed 2025-02-07 |
| 2022-12-31 | -$1.10M 10-K · filed 2025-02-07 |
| 2021-12-31 | $10.70M 10-K · filed 2024-02-14 |
| 2020-12-31 | -$40.80M 10-K · filed 2023-02-14 |
| 2019-12-31 | $3.70M 10-K · filed 2022-02-11 |
| 2018-12-31 | $5.60M 10-K · filed 2021-02-16 |
| 2017-12-31 | -$800.00K 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |